Division of Vascular Surgery, Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY.
Division of Vascular Surgery, Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY.
J Vasc Surg. 2018 Sep;68(3):683-692. doi: 10.1016/j.jvs.2017.12.039. Epub 2018 Mar 13.
The ideal treatment option for patients with complex aneurysm morphology remains highly debated. The aim of this study was to investigate the impact of endovascular aneurysm repair (EVAR) with active fixation on outcomes in patients with complex aneurysm morphology.
There were 340 consecutive patients who underwent EVAR using active fixation devices, 234 with active infrarenal fixation (AIF; Gore Excluder; W. L. Gore & Associates, Flagstaff, Ariz) and 106 with active suprarenal fixation (ASF; 85 Medtronic Endurant [Medtronic, Santa Rosa, Calif] and 21 Cook Zenith [Cook Medical, Bloomington, Ind]). Demographics, comorbidities, anatomic features, and outcomes were analyzed for patients receiving devices with active fixation. Outcomes of using active fixation in necks with <15-mm neck lengths, >60-degree infrarenal neck angle (β), >30-mm infrarenal neck diameter, severe aortic neck calcification or thrombus, and nonstraight neck morphology were evaluated.
Of the 340 patients, 106 (78 men; mean age, 74.5 ± 9.3 years at the time of surgery) received implants with ASF and 234 (191 men; mean age, 74.6 ± 8.9 years at the time of surgery) received implants with AIF. In comparing AIF and ASF devices, patients in the suprarenal fixation group had significantly shorter follow-up time (25 ± 17 months vs 44.3 ± 32 months; P < .0001). Patients in the ASF group had shorter aortic neck lengths (25.5 ± 15.1 mm vs 28.6 ± 14.9 mm; P = NS) and significantly larger infrarenal neck diameters (25.9 ± 6.3 mm vs 23.4 ± 3.2 mm; P < .0001) and aneurysm diameters (59.9 ± 11.6 mm v. 55.9 ± 10.0 mm; P = .002). Outcomes were similar between groups, with no significant differences in reintervention, proximal endoleak, sac growth, abdominal aortic aneurysm-related death, or rupture. Of the complex anatomic neck features investigated, neck diameter >30 mm and nonstraight neck morphology had the highest rates of reintervention in ASF devices.
In cases of hostile infrarenal neck morphology, ASF appears to be used more frequently. Our data suggest that ASF may be useful for certain patients but may be unfavorable for others, such as those with wide necks or several difficult neck features. Nevertheless, further research is needed to evaluate more optimal treatment options, such as fenestrated EVAR, branched EVAR, and endovascular adjuncts such as EndoAnchors (Aptus Endosystems, Sunnyvale, Calif), in dealing with high-risk anatomic characteristics that may not be optimally managed with standard EVAR devices with active fixation.
对于复杂动脉瘤形态的患者,理想的治疗选择仍存在很大争议。本研究旨在探讨使用带主动固定装置的血管内动脉瘤修复术(EVAR)对复杂动脉瘤形态患者结局的影响。
对 340 例连续接受主动固定装置行 EVAR 的患者进行回顾性分析,其中 234 例采用肾下主动固定(AIF;戈尔 Excluder;戈尔公司,弗拉格斯塔夫,亚利桑那州),106 例采用肾上主动固定(ASF;85 例美敦力 Endurant [美敦力,圣罗莎,加利福尼亚州]和 21 例库克 Zenith [库克医疗,布鲁明顿,印第安纳州])。分析接受带主动固定装置患者的人口统计学、合并症、解剖特征和结局。评估用于颈长<15mm、肾下颈角(β)>60°、肾下颈直径>30mm、严重主动脉颈钙化或血栓形成以及非直颈形态的主动固定装置的疗效。
在 340 例患者中,106 例(78 例男性;手术时的平均年龄为 74.5±9.3 岁)接受了带 ASF 的植入物,234 例(191 例男性;手术时的平均年龄为 74.6±8.9 岁)接受了带 AIF 的植入物。在比较 AIF 和 ASF 装置时,肾上固定组患者的随访时间明显较短(25±17 个月 vs 44.3±32 个月;P<0.0001)。ASF 组患者的主动脉颈长度更短(25.5±15.1mm vs 28.6±14.9mm;P=NS),肾下颈直径显著更大(25.9±6.3mm vs 23.4±3.2mm;P<0.0001),以及动脉瘤直径更大(59.9±11.6mm vs 55.9±10.0mm;P=0.002)。两组患者的结局相似,再干预、近端内漏、瘤腔生长、与腹主动脉瘤相关的死亡或破裂均无显著差异。在所研究的复杂解剖颈特征中,颈直径>30mm 和非直颈形态是 ASF 装置再干预的最高发生率。
在肾下颈形态不佳的情况下,ASF 的应用似乎更为频繁。我们的数据表明,ASF 可能对某些患者有用,但对其他患者可能不利,例如颈宽或存在多种困难颈特征的患者。然而,需要进一步研究以评估更优化的治疗选择,如开窗 EVAR、分支 EVAR 和血管内辅助器械(如 EndoAnchors;Aptus Endosystems,桑尼维尔,加利福尼亚州),以处理可能无法通过标准带主动固定装置的 EVAR 设备最佳管理的高危解剖特征。